Medicina
Facultad
University of Nebraska Medical Center
Omaha, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Nebraska Medical Center (21)
2024
-
Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus
Scientific reports, Vol. 14, Núm. 1, pp. 3445
2023
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Early switch from intravenous to oral antibiotic treatment in bone and joint infections
Clinical Microbiology and Infection, Vol. 29, Núm. 9, pp. 1133-1138
-
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
Intensive Care Medicine, Vol. 49, Núm. 2, pp. 142-153
-
Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK)
Kidney International Reports, Vol. 8, Núm. 8, pp. 1542-1552
2022
-
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 2, pp. 659-670
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Strategies for implementation of a multidisciplinary approach to the treatment of nosocomial infections in critically ill patients
Expert Review of Anti-Infective Therapy, Vol. 19, Núm. 6, pp. 759-767
2020
-
Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials
AIDS and Behavior, Vol. 24, Núm. 12, pp. 3473-3481
2019
-
New filovirus disease classification and nomenclature
Nature Reviews Microbiology
2018
-
A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill
Intensive Care Medicine, Vol. 44, Núm. 6, pp. 742-759
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
-
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, but Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial
Medicine (United States), Vol. 95, Núm. 6
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
2012
-
Human immunodeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy
Cancer, Vol. 118, Núm. 21, pp. 5270-5277
-
Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies
Breast Cancer Research and Treatment, Vol. 134, Núm. 2, pp. 583-593